{"id":"W4405861407","doi":"10.1016/j.lungcan.2024.108066","title":"FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)","year":2024,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Exon; Oncology; Internal medicine; Chemotherapy; Mutation; Cancer research; Gene; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007292371,0.0007407004,0.002068609,0.0003846155,0.0001163374,0.0007829074,0.000804102,0.0007294439,0.007293489],"category_scores_gemma":[0.0007193691,0.0001835807,0.002244216,0.00051472,0.0001444132,0.000407229,0.0002523301,0.002336276,0.0008760652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005564828,"about_ca_system_score_gemma":0.0008028371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001671822,"about_ca_topic_score_gemma":0.006202274,"domain_scores_codex":[0.999873,0.00004245259,0.00001562271,0.00002027082,0.00002536846,0.00002325491],"domain_scores_gemma":[0.9998567,0.00006934157,0.00003734495,0.00000370281,0.00001408064,0.00001888344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02463894,0.000726628,0.0005059057,0.05874557,0.007168221,0.0001267497,0.00008392684,0.001808376,0.003614547,0.001432114,0.04793112,0.853218],"study_design_scores_gemma":[0.2189548,0.04116371,0.01531297,0.03826275,0.05019545,0.001681152,0.0003109931,0.00278761,0.004557925,0.004776833,0.6217929,0.0002028965],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01483856,0.9738617,0.0006174524,0.001316166,0.00101982,0.0004062484,0.001668889,0.0001083242,0.006162865],"genre_scores_gemma":[0.06833165,0.9155034,0.001347499,0.004721604,0.0003623089,0.0005001909,0.002146015,0.00004152409,0.007045691],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007293489,"threshold_uncertainty_score":0.02439916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04779677523494436,"score_gpt":0.4626471629771375,"score_spread":0.4148503877421932,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}